Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity | MicrobiomeTrials

← Back to trials

NCT06979531

Efficacy and Safety of IMVT-1402 in Adult Participants With Primary Sjogren's Disease With Moderate to Severe Systemic Disease Activity

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-06-30Est. Completion: 2028-07

Enrollment target: 180 participants

Locations

Site Number - 1027, Covina, California, United States
Site Number - 1007, El Cajon, California, United States
Site Number - 1016, Menifee, California, United States
Site Number - 1029, Thousand Oaks, California, United States
Site Number - 1026, Upland, California, United States
Site Number - 1014, Fort Collins, Colorado, United States
Site Number - 1018, Hollywood, Florida, United States
Site Number - 1021, Jupiter, Florida, United States
Site Number - 1002, Miami, Florida, United States
Site Number - 1004, Tamarac, Florida, United States
Site Number - 1025, Tampa, Florida, United States
Site Number - 1012, Chicago, Illinois, United States
Site Number - 1033, Orland Park, Illinois, United States
Site Number - 1030, Lake Charles, Louisiana, United States
Site Number - 1028, New Orleans, Louisiana, United States
Site Number - 1032, Canton, New York, United States
Site Number - 1006, Mineola, New York, United States

Other microbiome trials you might be interested in

Comprehensive Evaluation of Clinical and Biopsychosocial Characteristics in Primary Sjögren's DiseaseCompleted

Sjogren's Syndrome

Following the guidance of individuals with primary Sjögren's Syndrome who receive diagnosis, routine medical care, and t…

Ankara, Turkey (Türkiye)Completed Dec 30, 2024

Phase 3 Study of Telitacicept in Active Primary Sjögren's DiseasePhase 3Recruiting

Primary Sjogren's Disease

Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)

Chandler, United StatesEst. completion Dec 2028

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.